Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Jan 06, 2022 4:20pm
174 Views
Post# 34290578

RE:RE:New base $2

RE:RE:New base $2

Rix,

My objective is to get a return on my investment.  I have no need to ridicule you but I do find you the most annoying poster . You brought up $2 thing today. I just responded . Catalysts have  the ability to really change the outlook of the company versus a year ago .

I stand corrected  it was 70 cents that yiu sold and it went up to 2.80 before returning to 1.20. What was your glorious wisdom in selling at that point ?  That there alone  attests to your investment advice .

As for what and when I sell that's none of your business Rix. 

Getting back to Sva. Friday is the last day before Monday's update at JPMorgan. I hope the share price stays above $2 next week. The real catalyst will be a pharma deal.
 

It will be up to management to deliver, the ball is their court. As long as the competitors do not make any progress before conformal trial getting started, we should trade in the $2 plus range ,$3 plus if the pharma deal is any decent .

Ms Sally 

<< Previous
Bullboard Posts
Next >>